PHARMACEUTICAL PRESCRIPTION DRUGS

Brand Owner (click to sort) Address Description
DAXIM ORION CORPORATION ORIONINTIE 1 ESPOO 02200 Finland PHARMACEUTICAL PRESCRIPTION DRUGS FOR THE TREATMENT OF NEUROLOGICAL, CARDIOVASCULAR, RESPIRATORY OR HORMONAL DISEASES AND DISORDERS;
MYTERGY ORION CORPORATION ORIONINTIE 1 ESPOO 02200 Finland PHARMACEUTICAL PRESCRIPTION DRUGS FOR THE TREATMENT OF CARDIOVASCULAR, NEUROLOGICAL AND PSYCHIATRIC DISEASES AND DISORDERS;
PEXYLOR ORION CORPORATION ORIONINTIE 1 ESPOO 02200 Finland PHARMACEUTICAL PRESCRIPTION DRUGS FOR THE TREATMENT OF NEUROLOGICAL, CARDIOVASCULAR, RESPIRATORY AND HORMONAL DISEASES AND DISORDERS;
STALEEVO ORION CORPORATION ORIONINTIE 1 ESPOO 02200 Finland PHARMACEUTICAL PRESCRIPTION DRUGS FOR THE TREATMENT OF CARDIOVASCULAR, NEUROLOGICAL AND PSYCHIATRIC DISEASES AND DISORDERS;
STALEVO ORION CORPORATION ORIONINTIE 1 ESPOO 02200 Finland PHARMACEUTICAL PRESCRIPTION DRUGS FOR THE TREATMENT OF PARKINSON'S DISEASE;
STALIVO ORION CORPORATION ORIONINTIE 1 ESPOO 02200 Finland PHARMACEUTICAL PRESCRIPTION DRUGS FOR THE TREATMENT OF CARDIOVASCULAR, NEUROLOGICAL AND PSYCHIATRIC DISEASES AND DISORDERS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A prescription verification system includes a database that contains a plurality of spectral signatures corresponding to identified pharmaceuticals. A multimodal multiplex sampling (MMS) spectrometer obtains a spectra of a pharmaceutical to be identified and verified. The pharmaceutical can be inside or out of a vial. The prescription verification system includes algorithms for matching spectra of pharmaceuticals to be verified obtaining using the MMS spectrometer to spectral signatures contained in the database corresponding to identified pharmaceuticals. The prescription verification system further includes algorithms for identifying such pharmaceuticals to be verified.